Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedThe history now shows a new site revision, v3.5.4, replacing the prior v3.5.3. This indicates a small update to the page's release notes in the history log.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version label was applied (switching from v3.5.2 to v3.5.3). This reflects a site software/version change rather than a change to the trial’s recorded information.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now shows Revision: v3.5.2 and no longer displays Revision: v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedA new revision entry v3.5.0 was added to the page history, and v3.4.3 is shown as a deletion.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check81 days agoChange DetectedThe Study Status and Recruitment Status were updated to Completed, replacing the previous Active, not recruiting status.SummaryDifference0.2%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.